Erratum to: Exercise Therapy in the Management of Solid Tumors (Current Treatment Options in Oncology (2010) 11 (73-86))

Current Treatment Options in Oncology

Volumn 11, Issue 3-4, 2010, Pages 73-86

  Jones, Lee W ^a   Peppercorn, Jeffrey ^a   Scott, Jessica M ^a   Battaglini, Claudio ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 79951949368     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-010-0132-2     Document Type: Erratum

References (95)

1. Morris JN, Heady JA, Raffle PA, et al.: Coronary heartdisease and physical activity of work. Lancet 1953, 265:1111-1120; concl.
2. Morris JN, Heady JA, Raffle PA, et al.: Coronary heartdisease and physical activity of work. Lancet 1953, 265:1053-1057; contd.
3. Schwartz AL, Winters-Stone K, Gallucci B: Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 2007, 34:627-633.
4. Warburton DE, Nicol CW, Bredin SS: Health benefits of physical activity: the evidence. CMAJ 2006, 174:801-809.
5. Pate RR, Pratt M, Blair SN, et al.: Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995, 273:402-407.
6. Byers T, Nestle M, McTiernan A, et al.: American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2002, 52:92-119. (Pubitemid 34256835)
7. Jones LW, Peppercorn J: Exercise research: early promise warrants further investment. Lancet Oncol 2010, 11:408-410.
8. Brown JK, Byers T, Doyle C, et al.: Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2003, 53:268-291. (Pubitemid 37270571)
9. Winningham ML, MacVicar MG: The effect of aerobic exercise on patient reports of nausea. Oncol Nurs Forum 1988, 15:447-450.
10. Winningham ML, MacVicar MG, Bondoc M, et al.: Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy. Oncol Nurs Forum 1989, 16:683-689.
11. MacVicar MG, Winningham ML, Nickel JL: Effects of aerobic interval training on cancer patients' functional capacity. Nurs Res 1989, 38:348-351. (Pubitemid 19282341)
12. Winningham ML: Walking program for people with cancer. Getting started. Cancer Nurs 1991, 14:270-276.
13. Gianni L, Dombernowsky P, Sledge G, et al.: Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer. Ann Oncol 2001, 12:1067-1073. (Pubitemid 32834486)
14. Speck RM, Courneya KS, Masse LC, et al.: An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010, 4:87-100.
15. Kolden GG, Strauman TJ, Ward A, et al.: A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefits. Psychooncology 2002, 11:447-456.
16. Jones LW, Eves ND, Courneya KS, et al.: Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts. Clin Cancer Res 2005, 11:6695-6698. This preclinical study is the first to investigate the potential interaction between exercise and chemotherapy efficacy in mouse model of cancer. (Pubitemid 41339011)
17. Holmes MD, Chen WY, Feskanich D, et al.: Physical activity and survival after breast cancer diagnosis. JAMA 2005, 293:2479-2486. This epidemiological study was the first to show that regular exercise is associated with substantial reductions in cancerspecific and all-cause mortality following a breast cancer diagnosis, relative to inactive women. (Pubitemid 40705729)
18. Courneya KS, Booth CM, Gill S, et al.: The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Curr Oncol 2008, 15:279-285. This is the first randomized trial to investigate the effects of exercise training on clinical outcome in any cancer population.
19. Segal R, Evans W, Johnson D, et al.: Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 2001, 19:657-665. (Pubitemid 32119079)
20. Courneya KS, Segal RJ, Mackey JR, et al.: Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 2007, 25:4396-4404. (Pubitemid 350013845)
21. Meyerhardt JA, Ogino S, Kirkner GJ, et al.: Interaction of molecular markers and physical activity on mortality in patients with colon cancer. Clin Cancer Res 2009, 15:5931-5936.
22. Jones LW, Demark-Wahnefried W: Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol 2006, 7:1017-1026. (Pubitemid 44804143)
23. McNeely ML, Campbell KL, Rowe BH, et al.: Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 2006, 175:34-41. (Pubitemid 44065189)
24. Markes M, Brockow T, Resch KL: Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev, CD005001, 2006.
25. Schmitz KH, Holtzman J, Courneya KS, et al.: Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2005, 14:1588-1595. (Pubitemid 40995066)
26. Friendenreich CM, Courneya KS: Exercise as rehabilitation for cancer patients. Clin J Sport Med 1996, 6:237-244.
27. Stevinson C, Lawlor DA, Fox KR: Exercise interventions for cancer patients: systematic review of controlled trials. Cancer Causes Control 2004, 15:1035-1056. (Pubitemid 41449283)
28. Jones LW, Liang Y, Pituskin EN, et al.: Effect of exercise training on cardiorespiratory fitness in patients with cancer: a meta-analysis. J Clin Oncol, submitted.
29. Jones LW, Eves ND, Haykowsky M, et al.: Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 2009, 10:598-605. This paper comprehensively reviews the potential physiologic and molecular mechanisms underlying poor exercise tolerance in cancer patients. It also reviews the efficacy and mechanisms of aerobic training to prevent and/or treat exercise impairment.
30. Myers J, Prakash M, Froelicher V, et al.: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002, 346:793-801. (Pubitemid 34987553)
31. Gulati M, Black HR, Shaw LJ, et al.: The prognostic value of a nomogram for exercise capacity in women. N Engl J Med 2005, 353:468-475. (Pubitemid 41127291)
32. Ekelund LG, Haskell WL, Johnson JL, et al.: Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med 1988, 319:1379-1384.
33. Sandvik L, Erikssen J, Thaulow E, et al.: Physicalfitnessas a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med 1993, 328:533-537. (Pubitemid 23053829)
34. Erikssen G, Liestol K, Bjornholt J, et al.: Changes in physical fitness and changes in mortality. Lancet 1998, 352:759-762. (Pubitemid 28404556)
35. Mentzer SJ, Swanson SJ: Treatment of patients with lung cancer and severe emphysema. Chest 1999, 116:477S-479S. (Pubitemid 30013162)
36. Choong CK, Mahesh B, Patterson GA, et al.: Concomitant lung cancer resection and lung volume reduction surgery. Thorac Surg Clin 2009, 19:209-216.
37. Colice GL, Shafazand S, Griffin JP, et al.: Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidencedbased clinical practice guidelines (2nd edition). Chest 2007, 132:161S-177S. (Pubitemid 47502806)
38. Torchio R, Guglielmo M, Giardino R, et al.: Exercise ventilatory inefficiency and mortality in patients with chronic obstructive pulmonary disease undergoing surgery for non-small-cell lung cancer. Eur J Cardiothorac Surg.
39. Kasikcioglu E, Toker A, Tanju S, et al.: Oxygen uptake kinetics during cardiopulmonary exercise testing and postoperative complications in patients with lung cancer. Lung Cancer 2009, 66:85-88.
40. Bobbio A, Chetta A, Internullo E, et al.: Exercise capacity assessment in patients undergoing lung resection. Eur J Cardiothorac Surg 2009, 35:419-422.
41. Brunelli A, Belardinelli R, Refai M, et al.: Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest 2009, 135:1260-1267.
42. 2peak predicts mortality following a diagnosis of cancer.
43. Jones LW, Peddle CJ, Eves ND, et al.: Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer 2007, 110:590-598. (Pubitemid 47106148)
44. Bobbio A, Chetta A, Ampollini L, et al.: Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg 2008, 33:95-98. (Pubitemid 350266355)
45. Demark-Wahnefried W, George SL, Switzer BR, et al.: Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer. Clin Trials 2008, 5:262-272.
46. Lin DW, Neuhouser ML, Schenk JM, et al.: Low-fat, low-glycemic load diet and gene expression in human prostate epithelium: a feasibility study of using cDNA microarrays to assess the response to dietary intervention in target tissues. Cancer Epidemiol Biomarkers Prev 2007, 16:2150-2154. (Pubitemid 47621193)
47. Demark-Wahnefried W, Polascik TJ, George SL, et al.: Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev 2008, 17:3577-3587.
48. Jones LW, Eves ND, Peterson BL, et al.: Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer 2008, 113:3430-3439.
49. Segal RJ, Reid RD, Courneya KS, et al.: Resistanceexercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003, 21:1653-1659. (Pubitemid 46638574)
50. Galvao DA, Newton RU: Review of exercise intervention studies in cancer patients. J Clin Oncol 2005, 23:899-909. (Pubitemid 46237443)
51. Courneya KS, Sellar CM, Stevinson C, et al.: Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol 2009, 27:4605-4612.
52. Windsor PM, Nicol KF, Potter J: A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 2004, 101:550-557. (Pubitemid 38970606)
53. Courneya KS, Jones LW, Peddle CJ, et al.: Effects of aerobic exercise training in anemic cancer patients receiving darbepoetin alfa: a randomized controlled trial. Oncologist 2008, 13:1012-1020.
54. Adamsen L, Quist M, Andersen C, et al.: Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 2009, 339: b3410.
55. Chen HX, Cleck JN: Adverse effects of anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol 2009, 6:465-477.
56. Kamba T, McDonald DM: Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 2007, 96:1788-1795. (Pubitemid 46912024)
57. Jones LW, Haykowsky MJ, Swartz JJ, et al.: Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007, 50:1435-1441. (Pubitemid 47494586)
58. Yeh ET, Tong AT, Lenihan DJ, et al.: Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 2004, 109:3122-3131.
59. Giordano SH, Kuo YF, Freeman JL, et al.: Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005, 97:419-424. (Pubitemid 40528604)
60. Harris EE, Correa C, Hwang WT, et al.: Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 2006, 24:4100-4106. (Pubitemid 46622285)
61. Chien AJ, Rugo HS: The cardiac safety of trastuzumab in the treatment of breast cancer. Expert Opin Drug Saf 9:335-346.
62. Hydock DS, Wonders KY, Schneider CM, et al.: Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain. Anticancer Res 2009, 29:4401-4407.
63. Wonders KY, Hydock DS, Schneider CM, et al.: Acute exercise protects against doxorubicin cardiotoxicity. Integr Cancer Ther 2008, 7:147-154.
64. Hydock DS, Lien CY, Schneider CM, et al.: Exercise preconditioning protects against doxorubicininduced cardiac dysfunction. Med Sci Sports Exerc 2008, 40:808-817.
65. Chicco AJ, Hydock DS, Schneider CM, et al.: Lowintensity exercise training during doxorubicin treatment protects against cardiotoxicity. J Appl Physiol 2006, 100:519-527. (Pubitemid 43671603)
66. Chicco AJ, Schneider CM, Hayward R: Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol Regul Integr Comp Physiol 2005, 289: R424-R431. (Pubitemid 41060497)
67. Haykowsky MJ, Mackey JR, Thompson RB, et al.: Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training. Clin Cancer Res 2009, 15:4963-4967. This is the first study to investigate the effects of exercise training on cardiac function in cancer patients undergoing HER-2 targeted therapy for early-stage breast cancer.
68. Courneya KS, Mackey JR, Bell GJ, et al.: Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 2003, 21:1660-1668. (Pubitemid 46638575)
69. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
70. Ganz PA: Harnessing personalised medicine to prevent late effects. Lancet Oncol 11:7-9.
71. Ganz PA, Hahn EE: Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol 2008, 26:759-767. (Pubitemid 351264389)
72. Jones LW, Haykowsky M, Pituskin EN, et al.: Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor-positive operable breast cancer. Oncologist 2007, 12:1156-1164. (Pubitemid 350106346)
73. Jones LW, Haykowsky M, Peddle CJ, et al.: Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracyclinetaxane- containing adjuvant chemotherapy and/or trastuzumab. Cancer Epidemiol Biomarkers Prev 2007, 16:1026-1031. (Pubitemid 46910108)
74. Jones LW, Eves ND, Mackey JR, et al.: Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer 2007, 55:225-232. (Pubitemid 46074225)
75. Jones LW, Eves ND, Mackey JR, et al.: Systemic inflammation, cardiorespiratory fitness, and quality of life in patients with advanced non-small cell lung cancer. J Thorac Oncol 2008, 3:194-195. (Pubitemid 351323198)
76. Herrero F, Balmer J, San Juan AF, et al.: Is cardiorespiratory fitness related to quality of life in survivors of breast cancer? J Strength Cond Res 2006, 20:535-540. (Pubitemid 44448640)
77. Jones LW, Friedman AH, West MJ, et al.: Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma. Cancer 116:695-704.
78. Jones LW, Eves ND, Kraus WE, et al.: The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design. BMC Cancer 10:155.
79. Jones LW, Douglas PS, Eves ND, et al.: Rationale and design of the exercise intensity trial (EXCITE): a randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer. BMC Cancer, submitted.
80. Galvao DA, Spry N, Taaffe DR, et al.: A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial. BMC Cancer 2009, 9:419.
81. Ciolac EG, Bocchi EA, Bortolotto LA, et al.: Effects of high-intensity aerobic interval training vs. moderate exercise on hemodynamic, metabolic and neuro-humoral abnormalities of young normotensive women at high familial risk for hypertension. Hypertens Res.
82. Tjonna AE, Lee SJ, Rognmo O, et al.: Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 2008, 118:346-354.
83. Tjonna AE, Stolen TO, Bye A, et al.: Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents. Clin Sci (Lond) 2009, 116:317-326.
84. Ibrahim EM, Al-Homaidh A: Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol.
85. Meyerhardt JA, Giovannucci EL, Ogino S, et al.: Physical activity and male colorectal cancer survival. Arch Intern Med 2009, 169:2102-2108.
86. Meyerhardt JA, Giovannucci EL, Holmes MD, et al.: Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006, 24:3527-3534. (Pubitemid 46630522)
87. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al.: Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006, 24:3535-3541. (Pubitemid 46630523)
88. Holick CN, Newcomb PA, Trentham-Dietz A, et al.: Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2008, 17:379-386. (Pubitemid 351272790)
89. Irwin ML, Smith AW, McTiernan A, et al.: Influence of pre-and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol 2008, 26:3958-3964.
90. Sternfeld B, Weltzien E, Quesenberry CP Jr., et al.: Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev 2009, 18:87-95.
91. Pierce JP, Stefanick ML, Flatt SW, et al.: Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 2007, 25:2345-2351. (Pubitemid 46999205)
92. Dal Maso L, Zucchetto A, Talamini R, et al.: Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 2008, 123:2188-2194.
93. Ballard-Barbash R, Hunsberger S, Alciati MH, et al.: Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst 2009, 101:630-643.
94. Jones LW, Eves ND, Haykowsky M, et al.: Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol 2008, 9:757-765. The use of cardiorespiratory fitness testing following a cancer diagnosis has markedly increased over the past decade. To this end, this paper provides cardiorespiratory fitness testing guidelines for scientists and clinicians performing exercise testing in cancer patients. (Pubitemid 352038314)
95. Lowe SS, Watanabe SM, Courneya KS: Physical activity as a supportive care intervention in palliative cancer patients: a systematic review. J Support Oncol 2009, 7:27-34.